A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an HMG-CoA reductase inhibitor

Details for Australian Patent Application No. 2010201739 (hide)

Owner Veloxis Pharmaceuticals A/S

Inventors Holm, Per; Norling, Tomas

Agent Spruson & Ferguson

Pub. Number AU-B-2010201739

Parent 2006212609

Filing date 30 April 2010

Wipo publication date 20 May 2010

Acceptance publication date 29 March 2012

International Classifications

A61K 31/216 (2006.01)

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

20 May 2010 Application Open to Public Inspection

  Published as AU-B-2010201739

20 May 2010 Complete Application Filed

25 August 2011 Alteration of Name

  The name of the applicant has been altered to Veloxis Pharmaceuticals A/S

29 March 2012 Application Accepted

  Published as AU-B-2010201739

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010201740-Method, apparatus and system for performing a zoom operation

2010201738-Misalignment-tolerant Coupling